Clinical Trial Update: Biomarkers in Samples From Patients With Endometrial Cancer

View source ↗

Summary

This clinical trial update reports that the biomarker study in endometrial cancer samples sponsored by Gynecologic Oncology Group has been withdrawn. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Lynch Syndrome

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Lynch Syndrome, Recurrent Uterine Corpus Carcinoma | Status: WITHDRAWN